USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ONCOTIDE PHARMACEUTICALS, INC.
Address:
BOX 110606, 79 TW ALEXANDER DR, BLDG 4401
RESEARCH TRIANGLE PARK, NC 27709-0606
Phone:
N/A
URL:
N/A
EIN:
127491353
DUNS:
967354064
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $600,000.00 2

Award List:

Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Dale J. Christensen – 919-801-2911
Research Institution:
OREGON HEALTH AND SCIENCE UNIVERSITY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Chronic Myelogenous Leukemia (CML) affects nearly 14,000 patients worldwide and is a disorder of the pluripotent hematopoietic stem cells with two distinct phases. The protracted myelopoliferative chronic phase is followed by a rapidly fatal blast crisis. In… More

Targeting c-Myc and Akt with PP2A reactivation therapy for the treatment of breas

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$300,000.00
Agency:
HHS
Principal Investigator:
Dale J. Christensen – 919-801-2911
Research Institution:
OREGON HEATLH AND SCIENCE UNIVERSITY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Each year in the United States over 270,000 women will be diagnosed with breast cancer and over 40,000 will die from the disease. While multiple forms of breast cancer exist, a common theme in most of the forms involvesaberrations in signal transduction pathways… More